Rashmi Chugh

16PUBLICATIONS
82CO-AUTHORS
Solid tumoursPredictive and prognostic markersMolecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 10, 2025
Immunocompetent Murine Models Recapitulate the Heterogeneous Tumor-Immune Microenvironment of Human Liposarcoma.

Amanda M Shafer, Emma Kenna, Lexi-Ann F Golden

|Aug 23, 2025
Thematic Analysis of Clinician Documentation Surrounding Treatment Discussions and Decision-Making in Patients With Desmoid Tumors.

Victoria Wytiaz, Tianyi Wang, Scott Schuetze

|May 13, 2025
A Phase II Multicenter Trial of Trabectedin in Combination with Olaparib in Patients with Advanced Unresectable or Metastatic Sarcoma.

Brittany L Siontis, John D Rice, Scott M Schuetze

|May 07, 2025
Phase II Study of Pexidartinib Plus Sirolimus in Unresectable Malignant Peripheral Nerve Sheath Tumors Identifies M2 Macrophage Activation.

Gulam A Manji, Liam J Stanton, Angela C Hirbe

|Apr 25, 2025
Safety and Efficacy of a Selective Inhibitor of Cyclin-dependent Kinase 9 (KB-0742) in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma.

Glenn J Hanna, Gregory M Cote, Rashmi Chugh

|Mar 01, 2024
Phase II Trial of nab-Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update.

Andrew J Wagner, Vinod Ravi, Richard F Riedel

Pageof 3

Frequent Collaborators

4 joint publications

Scott Okuno

3 joint publications

Scott M Schuetze

3 joint publications

Brian A Van Tine

2 joint publications

Edwin Choy